RT @ACCmediacenter
“Working as a team to optimize our patient outcomes is critical and really the way that we will be able to succeed in these endeavors,” #ACCCVT member @KristenPharmD commented on the COORDINATE Diabetes trial at #ACC23/#WCCardio. https://bit.ly/40c67UN @TCTMD @TCTMD_Yael

RT @Intermountain
Earlier this month, our team got the chance to present lots of research at the @ACCinTouch conference. But one really important part of going to these conferences is getting to interact with cardiology peers from across the country to share resources, ideas, and yes, puns. #ACC23

CARDIOLOGY QUESTION
Contradiction:
-Large (n=116K) dose-response study for exercise showing a lowering of all cause & CVD mortality endurance up to 900 m/w
-Smaller (n<600) #ACC23: endurance exercise WORSENS all plaque burden, even at moderate levels.

IMPLICATION Plaque⇏risk?

RT @HCPLiveCardio
At #ACC23, we sat down with @VietHeartPA to learn more about @Intermountain Healthcare's experience measuring Lp(a) and associations of increased levels with ASCVD risk translates to real-world populations.

http://ow.ly/kftg50NfICF

#Cardiology #Lipids

RT @MinnowWalsh
One more special moment from #ACC23
#MadamePresident @athenapoppas @pamelasdouglas @ditchhaporia @CathieBiga @ACCinTouch

RT @GiuseppeGalati_
5th wrap-up #ACC23
🔥 Collaborative analysis #PROMINENT + #REDUCE_IT + #STRENGTH
❤️‍🔥Confirmed that #inflammation measured by #hsCRP ⬆️ effect on #CV_risk & ☠️ than #LDL_C

@DrMarthaGulati @DLBhattMD @gcfmd @iamritu @mmamas1973 @Purviparwani @TomLuscher

https://bit.ly/3ZDBdob

RT @HCPLiveCardio
What was the top new data from #ACC23?

Hear perspectives from the continuum of the #cardiovascular care team in this recap of the @ACCinTouch 72nd annual scientific sessions.

http://ow.ly/Y3UM50NfgEb

@DLBhattMD @GreggWStone @VietHeartPA @ankeetbhatt @HeartBobH @safchat

RT @GiuseppeGalati_
👇#ACC23
Importance of inflammation ❤️‍🔥 even higher than #LDL_C values
@mvaduganathan
@FeliceGragnano @AL_Catapano @JJheart_doc @VietHeartPA @fikkumamoto @hvanspall @ShelleyZieroth @KardiologieHH @markcpetrie20 @PierpaoloPel @DBelardoMD @AnastasiaSMihai @Amarincorp @Cardioinfo_it

RT @ACCinTouch
The goal of the CLEAR Outcomes trial was to compare the safety and efficacy of bempedoic acid compared with placebo among patients with or at high risk for CVD and were intolerant of statin therapy. Read more: https://bit.ly/3mDNf20 #ACC23/#WCCardio

Antithombotics are no joke. More on board = more bleed risk.

🩸#PAD also is no joke. ⬆️⬆️ events. AntiThrombo help ⬇️events
🩸consider adding anticoag to antiplt (voyager/compass) in both PAD and/or CAD
🩸would love to hear thoughts on p2y12i+Xa rather than ASA+Xa
#ACC23

More on anti-thrombo

🩸Too bad vorapaxar went away
🩸arterial thrombosis: platelet activation + thrombus (dual pathway inhibition)
🩸Read Compass! Not just #PAD, but CAD (90% had it)=24% RRR on rivaroxaban👊🏾
🩸Voyager: early separation (3m), ongoing divergence.
#ACC23

What about antithrombolytics in #PAD?

🩸 Risk for MACE/MALE ⬆️w/presence of polyvasc and/or sx/event.
🩸ASA may help, crosses unity line tho
🩸p2y12 helps, modestly - ticag may not be better than clopido

#ACC23

#PAD - the forgotten #ASCVD component.

🦵🏾MI/CVA events higher in PAD than in prior MI/CVA pts!!!!
🦵🏾Low use of statins/other LLT in PAD 👀😮
🦵🏾#LLT effective in PAD: statinize!

#acc23

What did I learn from being a panelist at this #PAD session? A lot.

@baileyannRN @JVargheseMD @herbaronowMD @marcreixell @KimGSmolderen #acc23 @MarcBonaca

I love the randomness of life. Or perhaps it is not random.

@DrEugeneYang - saved me from turning around from the #acc23 #tweetup. I get anxiety in groups. He came out of an elevator just as I turned to leave from the Ritz-Carlton.

Result: up the elevator w/him. Thx 🙏🏾

So, there I was just walking past the most amazing group of cardiologists and they invited me to take a picture with them.

All amazing and accomplished experts.
Lucky #PhysicianAssociate. #advocacy #equity #acccvt #ACC23

RT @avolgman
Please join us today at #ACC23 to learn about CVD in Asian subgroups! We’re not low-risk!! 12:45 pm at Health Equity Hub. @sandylewis @gina_lundberg @DineshKalra @DrEugeneYang @DrToniyaSingh @DrLaxmiMehta @Purviparwani @mmamas1973 @drmalissawood @GarimaVSharmaMD @NitiCardio

#VitaminD has had back&forth data w/recent “neutral” clinical trials but “positive” analyses for reduced DM and dementia.

#ACC23 #PhysicianAssociate #HeartPA #PatientsHealthFirst

We are enrolling in the Target D trial (Heidi May, PI), an RCT in ACS pat…https://lnkd.in/g77QsuVP

Coronary calcium is pathognomic for coronary atherosclerosis. We looked at CAC from cardiact PET and stand alone CT. Does the distribution of CAC predict 90-d or 1-yr MACE?

#PA #HeartPA #PhysicianAssociate #ACC23

Over 7500 scans were analyzed and expec…https://lnkd.in/gx-zgMHx

RT @jasonmcarlton
That’s a wrap for #ACC23. I’m so lucky to work with an amazing team of ❤️ docs, ❤️ researchers and marketing/comm experts from across the @Intermountain system.

We work hard, and we have fun doing it! Here’s to #ACC24 in Atlanta!